tradingkey.logo
tradingkey.logo
Search

Crypto Founder Predicts This Altcoin Sweetheart Will Overtake Solana, But How Far Will It Go?

BitcoinistJun 1, 2026 6:00 PM
facebooktwitterlinkedin
View all comments0

BitMEX co-founder Arthur Hayes has predicted that the altcoin Hyperliquid will overtake Solana before this market cycle ends. The crypto founder has also reiterated his $150 price target for the HYPE token, predicting it will be reached by the start of the second half of the year. 

Arthur Hayes Predicts Hyperliquid Will Overtake Solana In Market Cap

In an X post, Hayes opined that Hyperliquid should, at a minimum, overtake Solana before this “bull run” is over. The crypto founder also remarked that his portfolio was in a bull market, even as another X user stated that the crypto market was in a bear market. It is worth noting that the BitMEX co-founder has recently revealed exposure to HYPE, ZEC, and NEAR, which are among the altcoins that have recorded significant gains over the past few weeks.  

Meanwhile, Hayes’s prediction that Hyperliquid will overtake Solana came while the altcoin was still trading below the psychological $70 price level and at a $15 billion market cap. Since then, HYPE has rallied to a new all-time high (ATH) above $73, boasting a market cap of $18 billion and overtaking Dogecoin to become the 9th largest crypto by market cap. 

Hyperliquid potentially overtaking Solana means the altcoin’s market cap could still rise above $48 billion, making it the 7th-largest crypto by market cap. It also means HYPE’s price could rise above $100, a development the crypto founder is confident will occur. Hayes recently reiterated that the altcoin will still rally to $150. 

Hayes has before now predicted that HYPE will rally to $150 by August this year. He predicted that this would happen as the Hyperliquid DEX continues to gain more traction, which will, in turn, boost fees earned on the platform and the token buybacks. It is worth noting that the DEX currently uses up to 99% of fees earned to buy and burn HYPE tokens. 

Arthur Hayes Challenges Kyle Samani

In another X post, Hayes challenged Solana advocate Kyle Samani to a “charitable bet.” He told him that he will put $100,000 on the line to a charity of Samani’s choice that HYPE outperforms any other current top crypto by market cap from now until year-end. The crypto founder then asked Samani to pick a coin that he thinks would outperform HYPE. 

Hyperliquid is currently the best-performing crypto among the top 10 cryptos by market cap with a year-to-date (YTD) gain of 188%. Justin Sun’s Tron is the only other crypto in the rankings that is green this year, with a YTD gain of 23%. 

At the time of writing, the Hyperliquid price is trading at around $73, up over 5% in the last 24 hours, according to data from CoinMarketCap.

Hyperliquid
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.